Standard InChI: InChI=1S/C22H30Cl2N10.C6H12O7/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;7-1-2(8)3(9)4(10)5(11)6(12)13/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2-5,7-11H,1H2,(H,12,13)/t;2-,3-,4+,5-/m.1/s1
Standard InChI Key: KUXUALPOSMRJSW-IFWQJVLJSA-N
Associated Targets(Human)
Skin 286 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Escherichia coli 133304 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Pseudomonas aeruginosa 123386 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Enterococcus 1748 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Serratia marcescens 3237 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Streptococcus mutans 2687 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Actinomyces naeslundii 215 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Actinomyces viscosus 309 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 505.46
Molecular Weight (Monoisotopic): 504.2032
AlogP: 4.18
#Rotatable Bonds: 9
Polar Surface Area: 167.58
Molecular Species: BASE
HBA: 4
HBD: 10
#RO5 Violations: 2
HBA (Lipinski): 10
HBD (Lipinski): 10
#RO5 Violations (Lipinski): 2
CX Acidic pKa:
CX Basic pKa: 10.45
CX LogP: 4.51
CX LogD: -1.30
Aromatic Rings: 2
Heavy Atoms: 34
QED Weighted: 0.14
Np Likeness Score: -0.36
References
1.Maeda S, Kita T, Meguro K.. (2009) Synthesis of novel 4,6-di(substituted)amino-1,2-dihydro-1,3,5-triazine derivatives as topical antiseptic agents., 52 (3):[PMID:19117423][10.1021/jm8014712]
2.Maseda H, Hashida Y, Konaka R, Shirai A, Kourai H.. (2009) Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens., 53 (12):[PMID:19752278][10.1128/aac.00631-09]
3.Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA.. (2008) Penetration of chlorhexidine into human skin., 52 (10):[PMID:18676882][10.1128/aac.00637-08]
4.Nakaminami H, Noguchi N, Sasatsu M.. (2010) Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus., 54 (10):[PMID:20660673][10.1128/aac.01065-09]
5.Coburn RA, Baker PJ, Evans RT, Genco RJ, Fischman SL.. (1978) In vitro antiplaque properties of a series of alkyl bis(biguanides)., 21 (8):[PMID:691009][10.1021/jm00206a024]
6.Patel, Anjali, Dey, Subhasis, Shokeen, Kamal, Karpinski, Tomasz M., Sivaprakasam, Senthilkumar, Kumar, Sachin, Manna, Debasis. (2021) Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity, 12 (6.0):[PMID:34223166][10.1039/d1md00091h]